Development and Validation of the Modified Charlson Comorbidity Index in Incident Peritoneal Dialysis Patients: A

Hyunjeong Cho1, Myoung-Hee Kim2, Hyo Jin Kim3

  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Insights

A modified Charlson Comorbidity Index (CCI) for peritoneal dialysis (PD) patients, the mCCI-IPD, improves mortality risk prediction. This new index offers better stratification for PD patients compared to the standard CCI.

Area of Science:

  • Nephrology
  • Epidemiology
  • Biostatistics

Background:

  • The standard Charlson Comorbidity Index (CCI) utility is debated in peritoneal dialysis (PD) patients due to potentially different comorbidity weights.
  • Accurate risk stratification is crucial for PD patient management and outcomes.

Purpose of the Study:

  • To develop and validate a modified CCI specifically for incident PD patients (mCCI-IPD).
  • To enhance mortality prediction and risk stratification in this population.

Main Methods:

  • Developed mCCI-IPD using Cox regression on a Korean cohort (n=7,606) of incident PD patients (2005-2008).
  • Validated prognostic performance using an independent cohort (n=664) with c-statistics and continuous net reclassification improvement (cNRI).

Main Results:

  • The modified index (mCCI-IPD) reassigned weights to 11 comorbidities significantly predicting mortality.
  • While both CCI and mCCI-IPD correlated with survival, mCCI-IPD showed a significant 38.2% improvement in mortality risk assessment via cNRI.
  • Reclassification improvements were significant in both patients with and without adverse events.

Conclusions:

  • The mCCI-IPD demonstrates superior performance in predicting mortality for incident PD patients compared to the standard CCI.
  • This modified index is recommended for statistical analysis and clinical decision-making in PD patient care.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.4K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
879
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
580
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
290
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
964